帕金森病患者使用平衡控制数据的隐藏马尔科夫模型
Khaled Safi1, Wael Hosny Fouad Aly2, Hassan Kanj2
1Computer Science Department, Jinan University, Tripoli P.O. Box 818, Lebanon.
Bioengineering (Basel, Switzerland)
|January 22, 2024
概括
一种新的隐藏马尔科夫模型 (HMM) 准确地区分了帕金森病 (PD) 患者与健康个体,使用原始稳定计数据. 这种方法达到高达98%的准确性,为PD的早期检测和管理提供了一个有前途的工具.
科学领域:
- 生物力学 生物力学
- 神经学 神经学
- 数据科学数据科学数据科学
背景情况:
- 人的姿势控制对于在静态和动态条件下保持平衡至关重要.
- 帕金森病 (PD) 严重损害了稳定性,增加了跌倒的风险.
- 对与PD相关的姿势缺陷的客观评估至关重要.
研究的目的:
- 开发和验证一种新的方法来区分患有PD的个体与健康对照.
- 使用原始稳定计数据评估隐藏的马尔科夫模型 (HMM) 的有效性.
主要方法:
- 使用隐藏的马尔科夫模型 (HMM) 来进行分类.
- 采用了来自60名参与者的原始,预处理的稳定度信号 (健康和PD).
- 评估模型在区分两个组的准确性.
主要成果:
- 在区分健康受试者和PD患者方面,HMM实现了高达98%的高准确率.
- 该方法使用未经处理的稳定计数据证明了其有效性.
- 在健康和PD组之间取得了成功的区分.
结论:
- 提出的基于HMM的方法为识别帕金森病提供了一个高度准确和高效的方法.
- 使用原始稳定计数据简化了诊断过程.
- 这种技术具有非侵入性PD诊断和监测的潜力.
相关概念视频
Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551


